Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 2—February 2009

Medical Procedures and Risk for Sporadic Creutzfeldt-Jakob Disease, Japan, 1999–2008

Tsuyoshi Hamaguchi, Moeko Noguchi-Shinohara, Ichiro Nozaki, Yosikazu Nakamura, Takeshi Sato, Tetsuyuki Kitamoto, Hidehiro Mizusawa, and Masahito YamadaComments to Author 
Author affiliations: Kanazawa University Graduate School of Medical Science, Kanazawa, Japan (T. Hamaguchi, M. Noguchi-Shinohara, I. Nozaki, M. Yamada); Jichi Medical University, Shimotsuke, Japan (Y. Nakamura); Kohnodai Hospital, Ichikawa, Japan (T. Sato); Tohoku University Graduate School of Medicine, Sendai, Japan (T. Kitamoto); Tokyo Medical and Dental University, Tokyo, Japan (H. Mizusawa); Creutzfeldt-Jakob Disease Surveillance Committee, Japan (Y. Nakamura, T. Sato, J. Mizusawa, T. Kitamoto, M. Yamada)

Main Article

Table 5

Characteristics of 5 sCJD patients who underwent neurosurgery or ophthalmic surgery at hospitals where other patients with prion diseases had previously undergone neurosurgery or ophthalmic surgery, Japan, 1999–2008*

Patient Type of CJD Onset of CJD Date of surgery Reason for surgery
1 sCJD 2003 Aug 1991 Aug Subarachinoid hemorrhage
dCJD 2001 May 1976 Spinal cord tumor

1986 Aug
Spinal cord tumor
2 sCJD 2002 Feb 1994 Sep Subdural hematoma
1997 Sep Cataract

1998 Jan
1987 Jan
3 sCJD 2001 Jan 1989 Apr Subarachinoid hemorrhage

1995 Jul
1980 Jul
4 sCJD 2001 Jul 1999 Spinal cord lesion (details unknown)

2001 Aug
1978 Sep
5 sCJD 2002 May 2002 Apr Cataract
sCJD 2002 May 1997 Aug Cataract
1999 Jan Cataract

*CJD, Creutzfeldt-Jakob disease; sCJD, sporadic CJD; dCJD, Creutzfeldt-Jakob disease associated with cadaveric dura mater graft.

Main Article

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.